Moderna Stock Trading Lower On Dismal Guidance, Analysts Cuts Price Targets Noting Competitive Pressure From GSK, Pfizer
European Equities Traded in the US as American Depositary Receipts Sharply Down in Friday Trading
GSK Declares $0.3843 Dividend
US FDA Expands Approval of GSK's Endometrial Cancer Treatment Jemperli
Citi Reaffirms Their Buy Rating on GlaxoSmithKline (GSK)
Kepler Capital Sticks to Its Hold Rating for GlaxoSmithKline (GSK)
Express News | GSK's Dostarlimab-Gxly FDA Indication Expanded For Endometrial Cancer With Chemotherapy
Who's to Blame as Moderna's Stock Falls Amid Slashed Guidance?
DZ BANK AG Remains a Hold on GlaxoSmithKline (GSK)
BofA Securities Maintains GlaxoSmithKline(GSK.US) With Sell Rating
Bank of America Securities Sticks to Their Sell Rating for GlaxoSmithKline (GSK)
Moderna Drops as Lower COVID Vaccine Sales Prompt Guidance Cut
Moderna Cuts Revenue Guidance Amid Steeper Competition -- Barrons.com
UK Stocks: GSK Shares Fall Despite Upgraded Outlook
US FDA Expands Jemperli (Dostarlimab) Plus Chemotherapy Approval to All Adult Patients With Primary Advanced or Recurrent Endometrial Cancer as the First and Only Immuno-oncology-based Treatment to Show an Overall Survival Benefit
GlaxoSmithKline To Go Ex-Dividend On August 16th, 2024 With 0.38567 USD Dividend Per Share
6-K: Gsk Delivers Continued Strong Performance and Upgrades 2024 Guidance
British Equities Await US Fed Rate Decision Upbeat
British Pharma Giant GSK's Blockbuster Shingles And Respiratory Syncytial Virus Vaccine Q2 Sales Miss Expectations, Cuts Annual Vaccine Revenue Guidance
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday Trading